TacticScaleTonghua Dongbao Pharmaceutical Co., Ltd.
Chinese drugmaker focused on insulin and diabetes treatments
Understand Tonghua Dongbao Pharmaceutical →What Tonghua Dongbao Pharmaceutical does
Tonghua Dongbao develops, makes and sells medicines in China and abroad, mainly for diabetes. Its range includes several types of insulin, a GLP-1 injection (liraglutide), and oral diabetes pills, plus insulin pens and needles. It also sells some traditional Chinese medicines and other drugs, and runs a digital platform that helps diabetes patients manage their condition.
How Tonghua Dongbao Pharmaceutical makes money
Most of its revenue comes from selling diabetes drugs, mainly insulin and GLP-1 injections plus oral hypoglycemics, along with the pens and needles used to inject them. Smaller amounts come from traditional Chinese and chemical medicines, and from side businesses such as plastic building materials, real estate, workshop leasing and pharmaceutical trading.
Products & services
- Insulin glargine injection
- Insulin aspart injection
- Human insulin injections
- Liraglutide injection
- Insulin pens and pen needles
- Chronic Disease Management Platform